Validating antibodies for detecting modified proteins
Method for the validation by Western analysis of affinity reagents against post-translationally modified proteins.
This study is working to make sure that the tools scientists use to find certain proteins in the lab are more accurate and reliable, which will help improve research and treatments for patients.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Abbratech, INC. NIH-funded |
| Lab location | 1 site (Branford, UNITED STATES) |
| Project ID | NIH-10931606 on NIH RePORTER |
What this research studies
This research focuses on improving the accuracy and reliability of antibodies used in biomedical research to detect specific proteins that have undergone post-translational modifications. The project aims to validate these antibodies through innovative methods, including a technique called MILKSHAKE and a new tool named Sundae, which assesses antibody specificity. By extending previous work, the researchers will analyze various modifications and enhance the detection of glycosylated proteins, which are often difficult to identify. This work is crucial for ensuring that researchers can trust the results of their experiments, ultimately benefiting patient care and treatment development.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include patients with conditions that involve post-translationally modified proteins, such as certain cancers.
Not a fit: Patients who do not have conditions related to protein modifications or who are not involved in biomedical research may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more reliable diagnostic tools and therapies for patients with various diseases, including cancers.
How similar studies have performed: Other research has shown success in validating antibodies for specific applications, but this approach to post-translational modifications is innovative and may provide new insights.
Where this research is happening
Branford, UNITED STATES
- Abbratech, INC. — Branford, United States (Active)
Researchers
- Principal investigator: Weiner, Michael P — Abbratech, INC.
- Study coordinator: Weiner, Michael P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.